Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,170
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18 - 55
Code: NCT05574140
Recruiting
The Influence of Energy Drinks on the Blood Oxygenation Concentration of the Optic Nerve
for
Healthy
Location: Montreal
Sponsor: Université de Montréal
Sex: All
Age: 18 - 30
Code: NCT01827150
Early_phase1, Recruiting
Effects of a Supervised Rehabilitation Program on Disease Severity in Spastic Ataxias
for
Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay,
Location: Montreal, Quebec, Saguenay
Sponsor: Laval University
Sex: All
Age: 16+
Code: NCT06261424
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for
NonSegmental Vitiligo
Location: Montreal, Ottawa, Quebec, Boston MA, Rochester NY,
Sponsor: Incyte Corporation
Sex: All
Age: 2 - 11
Code: NCT06548360
Phase3, Recruiting
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
for
Lichen Sclerosus
Location: Montreal, Quebec, Guelph, Newmarket, Richmond Hill,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT07335588
Phase3, Recruiting
Music Interventions for the Facilitation of Sleep in the Acute Geriatric Setting
for
Sleep Disturbance, Insomnia, Music Listening Intervention,
Location: Montreal
Sponsor: McGill University
Sex: All
Age: 65+
Code: NCT05398419
Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Montreal, Ottawa, Quebec, New York NY, Westbury NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase3, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Montreal, Schenectady NY, White Plains NY, Newark DE,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase3, Recruiting
Tranexamic Acid Use on Pain, Mobility and Bleeding Following Total Hip and Total Knee Arthroplasty
for
Postoperative Bleeding
Location: Montreal
Sponsor: St. Mary's Research Center, Canada
Sex: All
Age: 18+
Code: NCT06208267
Recruiting
Virtual Reality Music in Geriatric Inpatients
for
Older Adult, Hospitalization
Location: Montreal
Sponsor: St. Mary's Research Center, Canada
Sex: All
Age: 60+
Code: NCT06519253
Recruiting
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
for
Cancer of the Prostate, Anxiety
Location: Montreal
Sponsor: St. Mary's Research Center, Canada
Sex: All
Age: 18+
Code: NCT06363266
Recruiting
Interest of Functional Neuroimaging in Assessing Decision-making Capacity of Older People With Neurocognitive Disorders
for
Decision Making, Dementia, Aging
Location: Montreal
Sponsor: Centre Hospitalier Universitaire de Besancon
Sex: All
Age: 70+
Code: NCT03931148
Recruiting
New
Optimizing Hydroxyurea Dosage With Pharmakokinetic in Patients Suffering of Moderate to Severe Sickle Cell Anemia